Novartis AG (NVS) Receives "Buy" Rating from JPMorgan Chase & Co.
's stock had its "buy" rating restated by research analysts at JPMorgan Chase & Co. in a report released on Thursday.
from Biotech News
's stock had its "buy" rating restated by research analysts at JPMorgan Chase & Co. in a report released on Thursday.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments